# Submission rejected

## DRAFT REJECTED

**SPAR verdict:** `reject_critical` (3-0 unanimous reject).

## Proposed thesis (rejected)

> The Diet and Exercise plus Metformin to Treat Frailty in Obese Seniors (DEMFOS) study evaluates whether combining lifestyle therapy with a pharmacologic aging modulator can improve function and musculoskeletal integrity beyond either intervention alone, addressing a critical need in geriatric obesity care.

## Failed citation traces

- **alias_match** on `C045` (ref=0): alias 'Objective' NOT resolved (drift)
- **alias_match** on `C047` (ref=0): alias 'Lifestyle' NOT resolved (drift)
- **alias_match** on `C048` (ref=0): alias 'Change' NOT resolved (drift)
- **alias_match** on `C049` (ref=0): alias 'Seniors' NOT resolved (drift)

## Panel reviews

### `evidence_auditor` — `reject` (score 1)

The submission fails fundamentally on the evidence trace. The alias matches are completely nonsensical and indicate a total failure of the trace process. For example, the alias 'Design' is resolved to 'CARGLUMIC ACID', 'Interventions' to 'CANGRELOR', 'Therapy' to 'RESAMIRIGENE BILPARVOVEC', and 'Diet' to 'ETILAMFETAMINE'. These are unrelated pharmacological agents and do not support the claims regarding the DEMFOS study design or interventions.

Additionally, multiple critical aliases failed to resolve entirely (drift), including 'Objective', 'Lifestyle', 'Change', and 'Seniors'. Because the citations fail their trace and the resolved aliases are irrelevant to the claims, the evidence does not support the assertions.

**Flagged claims:** C045, C046, C047, C048, C049

### `domain_skeptic` — `reject` (score 2)

The submission suffers from severe 'off-topic drift' and mechanism inflation. While the claims describe a clinical trial (DEMFOS) regarding metformin and frailty, the underlying evidence traces are completely disconnected from the topic. The alias matching reveals that the 'evidence' being used to support these claims actually refers to unrelated substances such as Carglumic Acid, Cangrelor, Resamirigene Bilparvovec, and Etilamfetamine. This is a catastrophic failure of domain alignment.

**Flagged claims:** C045, C046, C047, C048, C049

### `final_judge` — `reject` (score 1)

I align fully with both the Evidence Auditor and the Domain Skeptic. The citation trace results are not merely flawed; they are hallucinatory. The resolution of key terms like 'Design', 'Interventions', and 'Diet' to completely unrelated pharmaceutical agents (e.g., Carglumic Acid, Cangrelor, Etilamfetamine) demonstrates a total collapse of the evidence chain. There is zero logical or medical connection between the claims regarding the DEMFOS study and the resolved aliases provided in the trace.

Because the supporting evidence is nonsensical and the alias matching is catastrophic, the claims are entirely unsupported. There is no dissent to weigh in this instance, as both prior reviewers correctly identified a fundamental failure in the submission's evidentiary basis.

**Flagged claims:** C045, C046, C047, C048, C049
